The results showed that the SMARCA4-R1157W HE mutant significantly promoted the CRC cell growth compared with SMARCA4-WT, while the SMARCA4-R1157W HO mutant showed a greater effect on cell proliferation than the SMARCA4-R1157W HE mutant. Here, SMARCA4 is linked to colorectal carcinoma.